Company Filing History:
Years Active: 2015-2018
Title: Nathalie Alet - Innovator in Therapeutic Compounds
Introduction
Nathalie Alet is an accomplished inventor based in Paris, France, known for her contributions to the field of pharmaceuticals. With a focus on innovative compounds that hold therapeutic potential, she has successfully patented two significant inventions that address critical health issues.
Latest Patents
Her most recent patented innovations include:
1. **Benzylhydroxide derivatives, preparation thereof and therapeutic use thereof** - This invention pertains to benzylhydroxide derivatives represented by a specific formula. It encompasses the preparation methods and therapeutic applications of these compounds, potentially leading to advancements in treatment options.
2. **Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application** - This patent features new sulphonylaminopyrrolidinone compounds with antithrombotic properties that inhibit blood clotting factors IXa and/or Xa. It outlines both the processes for synthesizing these compounds and their use as medications, aiming to enhance patient care in blood-related illnesses.
Career Highlights
Nathalie is affiliated with Sanofi, a leading global healthcare company dedicated to improving health through research and innovation. Her work within Sanofi has allowed her to explore and develop therapeutic solutions that address significant medical challenges.
Collaborations
Throughout her career, Nathalie has collaborated with notable peers, including Jérôme Meneyrol and Guillaume Barre. These collaborations have fostered a productive environment for innovation and have played a significant role in the development of her patented inventions.
Conclusion
Nathalie Alet's inventive spirit and her focus on creating valuable therapeutic agents highlight her dedication to advancing health solutions. Her patents reflect her commitment to innovation in pharmaceuticals, making her a notable figure in her field. As she continues her work at Sanofi, her contributions are poised to impact patient treatment and drug development positively.